ArticleEuropean heart journal open2026
Overall coronary disease burden modifies the prognostic benefit of CTO-PCI: a SYNTAX score-stratified meta-analysis.
Article in European heart journal open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Beyond the Diagnosis-Personalized Risk Stratification in Contemporary Cardiovascular Medicine.Life (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims: Extensive coronary artery disease (CAD) coexisting with chronic total occlusion (CTO) is associated with adverse outcomes, yet patients with advanced CAD are often underrepresented in randomized trials, and the prognostic impact of CTO percutaneous coronary intervention (CTO-PCI) across different levels of anatomical complexity remains uncertain. We aimed to determine whether the overall CAD burden, quantified by the SYNTAX score (SS), influences the prognostic effect of CTO-PCI. Methods and results: A systematic search of PubMed, Embase, Google Scholar, and Cochrane databases was conducted. Eligible studies compared successful CTO-PCI vs. no CTO-PCI and reported the mean SYNTAX score of the cohort. Two reviewers independently extracted data. The primary endpoint was annualized cardiovascular (CV) mortality. Pooled hazard ratios (HRs) were calculated using fixed- or random-effects models with inverse-variance weighting. Meta-regression explored the relationship between SS and CV mortality, and subgroup analyses were performed according to predefined SS categories. Seventeen studies (3 randomized and 14 prospective observational; n = 11 001) were included. Successful CTO-PCI was associated with significantly lower CV mortality compared with non-revascularization (HR 0.54; 95% CI 0.46-0.64; Conclusion: The survival benefit of CTO-PCI appears to increase with the extent of overall coronary disease, suggesting that patients with higher anatomical burden may derive greater prognostic benefit from successful CTO revascularization.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.